PRESCRIBING SYRINGES TO PREVENT HIV: A SURVEY OF INFECTIOUS DISEASE AND ADDICTION MEDICINE PHYSICIANS IN RHODE ISLAND

REFERENCES

• Centers for Disease Control and Prevention. 1999
   Google Scholar
• Holmberg S. D. The Estimated Prevalence and Incidence of HIV in 96 Large US Metropolitan Areas. Am. J. Public Health 1996; 86(5)642–654
   PubMed Web of Science ®Google Scholar
• Heimer R., Khoshnood K., Jariwalafreeman B., Duncan B., Harima Y. Hepatitis in Used Syringes: the Limits of Sensitivity of Techniques to Detect Hepatitis B Virus (HBV) DNA, Hepatitis C Virus (HCV) RNA, and Antibodies to HBV Core and HCV Antigens. J. Infect. Dis. 1996; 173: 997–1000
   PubMed Web of Science ®Google Scholar
• Kemp R., Miller J., Lungley S., Baker M. Injecting Behaviors and Prevalence of Hepatitis B, C, and D Markers in New Zealand Injecting Drug User Populations. N.Z. Med. J. 1998; 111(1060)50–53
   PubMed Web of Science ®Google Scholar
• Freeman R. C., Rodriguez G. M., French J. F. Seroprevalence and Risk Factors Associated With HTLV I/II Infection in Injection Drug Users in Northern New Jersey. J. Addict. Dis. 1995; 14(3)51–66
   PubMed Web of Science ®Google Scholar
• Vlahov D., Khabbaz R. F., Cohn S., Galai N., Taylor E., Kaplan J. E. Incidence and Risk Factors for Human T-lymphotropic Virus Type II (HTLV-II) Seroconversion Among Injecting Drug Users in Baltimore, Maryland. J. Acquir. Immune Defic. Syndr. 1995; 9: 89–96
   Google Scholar
• O'Connor P. G., Selwyn P. A., Schottenfeld R. S. Medical Care for Injection-drug Users with Human Immunodeficiency Virus Infection. N. Engl. J. Med. 1994; 331(7)450–459
   PubMed Web of Science ®Google Scholar
• Gleghorn A. A., Wright-De Aguero L., Flynn C. Feasibility of One-time Use of Sterile Syringes: a Study of Active Injection Drug Users in Seven United States Metropolitan Areas. J. Acquir. Immune Defic. Syndr. 1998; 18(Suppl. 1)S30–S36
   Google Scholar
• Gossop M., Griffiths P., Powis B., Strang J. Severity of Heroin Dependence and HIV Risk. II. Sharing injecting equipment. AIDS Care 1993; 2(5)159–168
   Web of Science ®Google Scholar
• Koester S. K. Copping, Running, and Paraphernalia Laws: Contextual Variables and Needle Risk Behavior Among Injection Drug Users in Denver. Hum. Organism 1994; 53: 287–295
   Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Update: syringe-exchange programs — United States, 1996. M.M.W.R. 1997; 46: 565–568
   PubMedGoogle Scholar
• Heimer R., Khoshnood K., Bigg D., Guydish J., Jung B. Syringe Use and Reuse: Effects of Syringe Exchange Programs in Four Cities. J. Acquir. Immune Defic. Syndr. 1998; 18(Suppl 1)S37–S44
   Google Scholar
• Hurley S. F., Jolley D. J., Kaldor J. M. Effectiveness of Needle-exchange Programs for Prevention of HIV Infection. Lancet 1997; 349: 1797–1800
   PubMed Web of Science ®Google Scholar
• Watters J. K., Estilo M. J., Clark G. L., Lorvick J. Syringe and Needle Exchange as HIV/AIDS Prevention for Injection Drug Users. J.A.M.A. 1994; 271: 115–120
   PubMed Web of Science ®Google Scholar
• Heimer R., Kaplan E. H., O'Keefe E., Khoshnood K., Altice F. Three Years of needle exchange in New Haven: What Have We Learned?. AIDS Public Policy J. 1994; 9: 59–74
   Google Scholar
• Groseclose S. L., Weinstein B., Jones T. S., Valloroy L. A., Fehrs L. J., Kassler W. J. Impact of Increased Legal Access to Needles and Syringes on Practices of Injection-drug Users and Police Officers — Connecticut, 1992–1993. J. Acquir. Immune Deffic. Syndr. Hum. Retrovirol. 1995; 10: 82–89
   PubMedGoogle Scholar
• Nelson K. E., Vlahov D., Cohn S., Lindsay A., Solomon L., Anthony J. C. Human Immunodeficiency Virus Infection in Diabetic Intravenous Drug Users. J.A.M.A. 1991; 266: 2259–2261
   PubMed Web of Science ®Google Scholar
• Burris S., Lurie P., Abrahamson D., Rich J. D. Physician Prescription of Sterile Injection Equipment: Time for Action. Ann Int Med. 2000; 133: 218–226
   PubMed Web of Science ®Google Scholar
• Rich J. D., Dickinson B., Liu K., Case P., Jesdale B., Ingegneri R. M., Nolan P. A. Strict Syringe Laws in Rhode Island are Associated with High Rates of Reusing Syringes and HIV Risks Among Injection Drug Users. J. Acquir. Immune Defic. Syndr. Human Retrovirol. 1998; 18: S140–S141
   Google Scholar
• RIDOH. 2000
   Google Scholar
• U.S. Public Health Service. HIV Prevention bulletin: medical advice for persons who inject illicit drugs. U.S. Public Health Service, Atlanta, GA and Rockville, MD 1997
   Google Scholar
• Normand J., Vlahov-Moses L. Preventing HIV transmission; the role of sterile syringes and bleach. National Academy Press, Washington, DC 1995
   Google Scholar
• U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd edition, Williams & Wilkins, Baltimore 1996
   Google Scholar
• Friedland G., Selwyn P. Infections (Excluding AIDS) in Injection Drug Users. Harrison's Principles of Internal Medicine. 14th Edition, 1998; 831–835
   Google Scholar
• Brooner R., Kidrof M., King V., Beilenson P., Suikos O., Vlahov D. Drug Abuse Treatment Success Among Needle Exchange Participants. Public Health Rep. 1998; 113(Suppl. 1)129–139
   PubMedGoogle Scholar
• Des Jarlais D. C., Marmor M., Paone D., Titus S., Shi Q., Perlis T., Jose B., Friedman S. R. HIV Incidence Among Injecting Drug Users in New York City Syringe Exchange Programs. Lancet 1996; 348: 987–991
   PubMed Web of Science ®Google Scholar
• Vlahov D., Junge B., Brookmeyer R., Cohn S., Riley E., Armenian H., Beilenson P. Reductions in High-risk Drug Use Behaviors Among Participants in the Baltimore Needle Exchange Program. J. Acquir. Immune Defic. Syndr. Human Retrovirol. 1997; 16: 400–406
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. AIDS Associated With Injecting-drug Use—United States 1995. M.M.W.R. 1996; 45: 392–398
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. HIV/AIDS surveillance report. U.S. Department of Health and Human Services, Public Health Service, Atlanta 1993
   Google Scholar